MacroGenics
MGNX
#9044
Rank
NZ$0.19 B
Marketcap
NZ$3.13
Share price
-5.41%
Change (1 day)
-23.07%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: NZ$0.19 Billion

As of March 2026 MacroGenics has a market cap of NZ$0.19 Billion. This makes MacroGenics the world's 9044th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.19 B12.57%
2025NZ$0.17 B-51.08%
2024NZ$0.35 B-61.9%
2023NZ$0.94 B45.23%
2022NZ$0.64 B-54.9%
2021NZ$1.44 B-19.16%
2020NZ$1.78 B

End of Day market cap according to different sources

On Mar 2nd, 2026 the market cap of MacroGenics was reported to be:

NZ$0.20 Billion
by Nasdaq info icon info icon
NZ$0.20 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$258.99 B 130,728.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.530 T 773,079.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$347.58 B 175,483.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$313.19 B 158,110.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$508.66 B 256,852.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$213.98 B 107,996.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$1.45 B 633.30%๐Ÿ‡บ๐Ÿ‡ธ USA